COVID-19 pandemic and its implications on elimination of hepatitis by 2030: Current and future prospects
DOI:
https://doi.org/10.47672/ejhs.703Keywords:
COVID-19, pandemic, contagion, hepatitis eliminationAbstract
Purpose: The purpose of this paper was to discuss the challenges and difficulties faced by health agencies in meeting the WHO objective of eliminating hepatitis amid the COVID-19 pandemic. In addition, this paper also elucidates the various solutions to these problems, so that a realistic way forward can be determined in order to deal with this chronic problem in an effective and timely manner.
Methodology: This was a theoretical paper.
Findings: The present world is witnessing an unprecedented global calamity in the form of COVID-19 pandemic. The impact of the contagion is so immense and wide-spread that it has practically brought the best economies and healthcare systems of the world to the verge of collapse. With the entire world focusing on the pandemic itself and its consequences, the emphasis on other major health issues has dwindled considerably. One of those essential and magnanimous tasks is the universal campaign for the elimination of hepatitis. The Global Health Sector Strategy (under the umbrella of WHO) has identified five key areas in which significant efforts are required in order to eliminate hepatitis from the world by 2030, which will be discussed in detail in this paper.
Recommendations: Amid the COVID-19 pandemic, a targeted effort is required by health agencies and other stake holders in order to eliminate hepatitis from the world by 2030. This would include satellite (point of care) testing for chronic viral hepatitis, application of telecommunications technology for treatment and follow-up, and practically educating primary care physicians to treat non-emergent and uncomplicated cases instead of referring them to specialist clinic.
Downloads
References
Waheed, Y., Siddiq, M., Jamil, Z., & Najmi, M. H. (2018). Hepatitis elimination by 2030: Progress and challenges. World journal of gastroenterology, 24(44), 4959–4961.
Smith, S., Harmanci, H., Hutin, Y., Hess, S., Bulterys, M., Peck, R., Rewari, B., Mozalevskis, A., Shibeshi, M., Mumba, M., Le, L. V., Ishikawa, N., Nolna, D., Sereno, L., Gore, C., Goldberg, D. J., & Hutchinson, S. (2019). Global progress on the elimination of viral hepatitis as a major public health threat: An analysis of WHO Member State responses 2017. JHEP reports : innovation in hepatology, 1(2), 81–89.
Jafri W, Siddiqui B, Awan S. (2018). HCV-discovery to elimination, “myth or reality”. Hepatoma Res, 4: 54.
Lancaster, K., Rhodes, T., & Rance, J. (2020). "Towards eliminating viral hepatitis": Examining the productive capacity and constitutive effects of global policy on hepatitis C elimination. The International journal on drug policy, 80, 102419.
Dahl, E. H., Zahid, H., Aslam, K., & Jafri, W. (2020). Leaving no one behind: Towards equitable global elimination of hepatitis C. Journal of global health, 10(1), 010308.
Wingrove, C., Ferrier, L., James, C., & Wang, S. (2020). The impact of COVID-19 on hepatitis elimination. The lancet. Gastroenterology & hepatology, 5(9), 792–794.
Tordrup, D., Hutin, Y., Stenberg, K., Lauer, J. A., Hutton, D. W., Toy, M., Scott, N., Bulterys, M., Ball, A., & Hirnschall, G. (2019). Additional resource needs for viral hepatitis elimination through universal health coverage: projections in 67 low-income and middle-income countries, 2016-30. The Lancet. Global health, 7(9), e1180–e1188.
World Health Organization. Global Health Sector Strategies on Viral Hepatitis 2016-2021. Available from: URL: http://apps.who.int/ gb/ebwha/pdf_files/WHA69/A69_32-en.pdf?ua=1
Ratzan, S. C., Bloom, B. R., El-Mohandes, A., Fielding, J., Gostin, L. O., Hodge, J. G., Hotez, P., Kurth, A., Larson, H. J., Nurse, J., Omer, S. B., Orenstein, W. A., Salmon, D., & Rabin, K. (2019). The Salzburg Statement on Vaccination Acceptance. Journal of health communication, 24(5), 581–583.
Nayagam, S., Thursz, M., Sicuri, E., Conteh, L., Wiktor, S., Low-Beer, D., & Hallett, T. B. (2016). Requirements for global elimination of hepatitis B: a modelling study. The Lancet. Infectious diseases, 16(12), 1399–1408.
Wolfe, R. M., & Sharp, L. K. (2002). Anti-vaccinationists past and present. BMJ (Clinical research ed.), 325(7361), 430–432.
Hogan, A. B., Jewell, B. L., Sherrard-Smith, E., Vesga, J. F., Watson, O. J., Whittaker, C., Hamlet, A., Smith, J. A., Winskill, P., Verity, R., Baguelin, M., Lees, J. A., Whittles, L. K., Ainslie, K., Bhatt, S., Boonyasiri, A., Brazeau, N. F., Cattarino, L., Cooper, L. V., Coupland, H., … Hallett, T. B. (2020). Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries: a modelling study. The Lancet. Global health, 8(9), e1132–e1141.
Hutin, Y. J., Bulterys, M., & Hirnschall, G. O. (2018). How far are we from viral hepatitis elimination service coverage targets?. Journal of the International AIDS Society, 21 Suppl 2(Suppl Suppl 2), e25050.
Miyahara, R., Jasseh, M., Gomez, P., Shimakawa, Y., Greenwood, B., Keita, K., Ceesay, S., D'Alessandro, U., & Roca, A. (2016). Barriers to timely administration of birth dose vaccines in The Gambia, West Africa. Vaccine, 34(29), 3335–3341.
Wiesen, E., Diorditsa, S., & Li, X. (2016). Progress towards hepatitis B prevention through vaccination in the Western Pacific, 1990-2014. Vaccine, 34(25), 2855–2862.
Woodring, J., Pastore, R., Brink, A., Ishikawa, N., Takashima, Y., & Tohme, R. A. (2019). Progress Toward Hepatitis B Control and Elimination of Mother-to-Child Transmission of Hepatitis B Virus - Western Pacific Region, 2005-2017. MMWR. Morbidity and mortality weekly report, 68(8), 195–200.
Altaf, A., Janjua, N. Z., & Hutin, Y. (2006). The cost of unsafe injections in pakistan and challenges for prevention program. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 16(9), 622–624.
Rich JD, Beckwith CG, Macmadu A, Marshall BDL, Brinkley-Rubinstein L, Amon JJ, Milloy MJ, King MRF, Sanchez J, Atwoli L, Altice FL. Clinical care of incarcerated people with HIV, viral hepatitis, or tuberculosis. Lancet. 2016 Sep 10;388(10049):1103-1114.
The Lancet Gastroenterology Hepatology (2020). Eliminating viral hepatitis in the COVID-19 era: weighing challenge and opportunity. The lancet. Gastroenterology & hepatology, 5(9), 789.
Vasylyeva, T. I., Smyrnov, P., Strathdee, S., & Friedman, S. R. (2020). Challenges posed by COVID-19 to people who inject drugs and lessons from other outbreaks. Journal of the International AIDS Society, 23(7), e25583.
Cooke, G. S., Andrieux-Meyer, I., Applegate, T. L., Atun, R., Burry, J. R., Cheinquer, H., Dusheiko, G., Feld, J. J., Gore, C., Griswold, M. G., Hamid, S., Hellard, M. E., Hou, J., Howell, J., Jia, J., Kravchenko, N., Lazarus, J. V., Lemoine, M., Lesi, O. A., Maistat, L., … Lancet Gastroenterology & Hepatology Commissioners (2019). Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission. The lancet. Gastroenterology & hepatology, 4(2), 135–184.
Chhatwal, J., Chen, Q., Wang, X., Ayer, T., Zhuo, Y., Janjua, N. Z., & Kanwal, F. (2019). Assessment of the Feasibility and Cost of Hepatitis C Elimination in Pakistan. JAMA network open, 2(5), e193613.
Lemoine, M., Shimakawa, Y., Njie, R., Taal, M., Ndow, G., Chemin, I., Ghosh, S., Njai, H. F., Jeng, A., Sow, A., Toure-Kane, C., Mboup, S., Suso, P., Tamba, S., Jatta, A., Sarr, L., Kambi, A., Stanger, W., Nayagam, S., Howell, J., … PROLIFICA investigators (2016). Acceptability and feasibility of a screen-and-treat programme for hepatitis B virus infection in The Gambia: the Prevention of Liver Fibrosis and Cancer in Africa (PROLIFICA) study. The Lancet. Global health, 4(8), e559–e567.
Blach, S., Kondili, L. A., Aghemo, A., Cai, Z., Dugan, E., Estes, C., Gamkrelidze, I., Ma, S., Pawlotsky, J. M., Razavi-Shearer, D., Razavi, H., Waked, I., Zeuzem, S., & Craxi, A. (2021). Impact of COVID-19 on global HCV elimination efforts. Journal of hepatology, 74(1), 31–36.
Guss, D., Sherigar, J., Rosen, P., & Mohanty, S. R. (2018). Diagnosis and Management of Hepatitis C Infection in Primary Care Settings. Journal of general internal medicine, 33(4), 551–557.
Hussein, N. R., Daniel, S., Mirkhan, S. A., Saleem, Z., Musa, D. H., Ibrahim, N., & Naqid, I. A. (2020). Impact of the Covid-19 pandemic on the elimination of hepatitis C virus in Duhok, Kurdistan, Iraq: A retrospective cross-sectional study. Journal of family medicine and primary care, 9(12), 6213–6216.
Downloads
Published
How to Cite
Issue
Section
License
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution (CC-BY) 4.0 License that allows others to share the work with an acknowledgment of the work’s authorship and initial publication in this journal.
